Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing

International Journal of Radiation Oncology Biology Physics

Volumn 95, Issue 1, 2016, Pages 120-130

  Gameiro, Sofia R ^a   Malamas, Anthony S ^a   Bernstein, Michael B ^b   Tsang, Kwong Y ^a   Vassantachart, April ^b   Sahoo, Narayan ^b   Tailor, Ramesh ^b   Pidikiti, Rajesh ^b   Guha, Chandan P ^c   Hahn, Stephen M ^b   Krishnan, Sunil ^b   Hodge, James W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELL ADHESION; CELL CULTURE; CELL MEMBRANES; CELLS; CYTOLOGY; DISEASES; MODULATION; MOLECULES; PATIENT TREATMENT; PHOTONS; RADIATION; STEM CELLS; T-CELLS; TUMORS;

CARCINOEMBRYONIC ANTIGEN; CELL SURFACE EXPRESSION; CYTOLYTIC ACTIVITIES; CYTOTOXIC T LYMPHOCYTES; INCREASING SENSITIVITIES; INTERCELLULAR ADHESION MOLECULE-1; METHODS AND MATERIALS; PROTON RADIATION THERAPY;

RADIOTHERAPY;

CALRETICULIN; CARCINOEMBRYONIC ANTIGEN; CD133 ANTIGEN; CD137 LIGAND; CD227 ANTIGEN; CD70 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HERMES ANTIGEN; HLA A2 ANTIGEN; HLA A24 ANTIGEN; INDUCIBLE T CELL COSTIMULATOR LIGAND; INTERCELLULAR ADHESION MOLECULE 1; MUCIN 1; OX40 LIGAND; PROGRAMMED DEATH 1 LIGAND 1; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; HLA ANTIGEN;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER STEM CELL; CD8+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE FUNCTION; MALE; PHOTON THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON THERAPY; PROTON THERAPY SYSTEM; RADIATION EXPOSURE; TUMOR MICROENVIRONMENT; UPREGULATION; BREAST NEOPLASMS; CELL MEMBRANE; CHORDOMA; FEMALE; IMMUNOLOGY; IMMUNOTHERAPY; LUNG NEOPLASMS; METABOLISM; MULTIMODALITY CANCER THERAPY; NEOPLASMS; PHOTON; PROCEDURES; PROSTATIC NEOPLASMS; RADIATION RESPONSE; RADIOTHERAPY DOSAGE; THERAPEUTIC USE; TUMOR CELL LINE;

BREAST NEOPLASMS; CALRETICULIN; CARCINOEMBRYONIC ANTIGEN; CELL LINE, TUMOR; CELL MEMBRANE; CHORDOMA; COMBINED MODALITY THERAPY; FEMALE; HLA ANTIGENS; HUMANS; IMMUNOMODULATION; IMMUNOTHERAPY; INTERCELLULAR ADHESION MOLECULE-1; LUNG NEOPLASMS; MALE; MUCIN-1; NEOPLASMS; NEOPLASTIC STEM CELLS; PHOTONS; PROSTATIC NEOPLASMS; PROTON THERAPY; RADIOTHERAPY DOSAGE; T-LYMPHOCYTES, CYTOTOXIC; UP-REGULATION;

EID: 84963553844     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2016.02.022     Document Type: Article

References (35)

1. S.R. Gameiro, A. Ardiani, A. Kwilas, and et al. Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens Oncoimmunology 3 2014 e28643
2. J.W. Hodge, C.T. Garnett, B. Farsaci, and et al. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic t lymphocytes and is distinct from immunogenic cell death Int J Cancer 133 2013 624 636
3. M. Chakraborty, S.I. Abrams, C.N. Coleman, and et al. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated t-cell killing Cancer Res 64 2004 4328 4337
4. C.T. Garnett, C. Palena, M. Chakraborty, and et al. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes Cancer Res 64 2004 7985 7994
5. C. Kudo-Saito, J. Schlom, K. Camphausen, and et al. The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors Clin Cancer Res 11 2005 4533 4544
6. J.H. Lawrence, C.A. Tobias, J.L. Born, and et al. Alpha and proton heavy particles and the bragg peak in therapy Trans Am Clin Climatol Assoc 75 1964 111 116
7. K.Y. Tsang, S. Zaremba, C.A. Nieroda, and et al. Generation of human cytotoxic t cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-cea vaccine J Natl Cancer Inst 87 1995 982 990
8. K.Y. Tsang, M. Zhu, C.A. Nieroda, and et al. Phenotypic stability of a cytotoxic t-cell line directed against an immunodominant epitope of human carcinoembryonic antigen Clin Cancer Res 3 1997 2439 2449
9. K.Y. Tsang, C. Palena, J. Gulley, and et al. A human cytotoxic t-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1 Clin Cancer Res 10 2004 2139 2149
10. C. Jochems, J.A. Tucker, M. Vergati, and et al. Identification and characterization of agonist epitopes of the MUC1-C oncoprotein Cancer Immunol Immunother 63 2014 161 174
11. J.A. Tucker, C. Jochems, B. Boyerinas, and et al. Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis Cancer Immunol Immunother 63 2014 1307 1317
12. A. Gelbard, C.T. Garnett, S.I. Abrams, and et al. Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments ctl-mediated lysis Clin Cancer Res 12 2006 1897 1905
13. T. Ogino, X. Wang, and S. Ferrone Modified flow cytometry and cell-elisa methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulum J Immunol Methods 278 2003 33 44
14. S.R. Gameiro, M.L. Jammeh, M.M. Wattenberg, and et al. Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing Oncotarget 5 2014 403 416
15. M.P. Chao, S. Jaiswal, R. Weissman-Tsukamoto, and et al. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47 Sci Translat Med 2 2010 63ra94
16. S. Di Maio, S. Yip, G.A. Al Zhrani, and et al. Novel targeted therapies in chordoma: An update Ther Clin Risk Manag 11 2015 873 883
17. F. Islam, V. Gopalan, R.A. Smith, and et al. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment Exp Cell Res 335 2015 135 147
18. C. Lagadec, E. Vlashi, L. Della Donna, and et al. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment Breast Cancer Res 12 2010 R13
19. F. Pajonk, E. Vlashi, and W.H. McBride Radiation resistance of cancer stem cells: The 4 R's of radiobiology revisited Stem Cells 28 2010 639 648
20. X. Zhang, S.H. Lin, B. Fang, and et al. Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation J Thorac Oncol 8 2013 1484 1491
21. F. Tommasino, and M. Durante Proton radiobiology Cancers (Basel) 7 2015 353 381
22. H. Paganetti Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer Phys Med Biol 59 2014 R419 R472
23. O. Sartor, B.N. Maalouf, C.R. Hauck, and et al. Targeted use of alpha particles: Current status in cancer therapeutics J Nucl Med Radiat Ther 3 2012 136 10.4172/2155-9619.1000136
24. C.D. Schlaff, A. Krauze, A. Belard, and et al. Bringing the heavy: Carbon ion therapy in the radiobiological and clinical context Radiat Oncol 9 2014 88
25. A.R. Kwilas, R.N. Donahue, M.B. Bernstein, and et al. In the field: Exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer Front Oncol 2 2012 104
26. J.L. Gulley, P.M. Arlen, A. Bastian, and et al. Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer Clin Cancer Res 11 2005 3353 3362
27. J.L. Gulley, R.A. Madan, K.Y. Tsang, and et al. A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver Expert Opin Biol Ther 11 2011 1409 1418
28. C. Heery, R. Madan, M. Bilusic, and et al. Interim analysis of a phase II randomized clinical trial of samrium-153 (SM-153) with or without PSA-TRICOM vaccine in metastatic castration-resistant prostate cancer after docetaxel J Clin Oncol 30 2012 Abstr. 2526
29. C. Palena, and D.H. Hamilton Immune targeting of tumor epithelial-mesenchymal transition via brachyury-based vaccines Adv Cancer Res 128 2015 69 93
30. National Cancer Institute. A randomized, double-blind, phase 2 trial of GI-6301 (yeast-brachyury vaccine) versus placebo in combination with standard of care definitive radiotherapy in locally advanced, unresectable, chordoma. Available at: https://clinicaltrials.gov/ct2/show/NCT02383498. Accessed September 28, 2015.
31. S.M. Hiniker, D.S. Chen, and S.J. Knox Abscopal effect in a patient with melanoma N Engl J Med 366 2012 2035 author reply 2035-2036
32. C. Twyman-Saint Victor, A.J. Rech, A. Maity, and et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer Nature 520 2015 373 377
33. A. Derer, L. Deloch, Y. Rubner, and et al. Radio-immunotherapy-induced immunogenic cancer cells as basis for induction of systemic anti-tumor immune responses - pre-clinical evidence and ongoing clinical applications Front Immunol 6 2015 505
34. A. Derer, B. Frey, R. Fietkau, and et al. Immune-modulating properties of ionizing radiation: Rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors Cancer Immunol Immunother 2015 Nov 21 [Epub ahead of print]
35. M.B. Bernstein, C.T. Garnett, H. Zhang, and et al. Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions Cancer Biother Radiopharm 29 2014 153 161